Is Foundayo a long-term medication?
Yes. Foundayo is designed as a long-term treatment, because obesity is a long-term chronic condition.
Foundayo (orforglipron) is a once-daily pill made by Eli Lilly and Company. It belongs to a group of medicines called GLP-1 agonists. They copy GLP-1, a hormone your gut releases after eating that lowers your appetite. These medicines only work while you continue to take them, and Foundayo dosage guidelines suggest it shouldn’t be taken in short courses.
Foundayo is one of the newer oral options for weight loss. Unlike the Wegovy pill, you do not need to take Foundayo on an empty stomach. You can take it at any time, with or without food.
In August 2026, Foundayo was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the UK market. A release date has not yet been revealed.
Think of obesity the way you would think of high blood pressure. Taking the medicine keeps the condition in check. Stop the medicine, and the condition comes back, because treatment controls obesity rather than curing it.
The ATTAIN-1 trial put numbers on that. Adults on the highest dose of Foundayo lost around 11% of their body weight across 72 weeks, or roughly 16 months. Side effects matched what the GLP-1 class already produces, and the trial found Foundayo safe and effective for weight loss. These weight loss results held while people stayed on treatment.
How long you stay on Foundayo depends on your goals and how well you respond to it.
Not every decision to stop comes down to the number on the scales. Some people will choose to stop treatment due to side effects. In the Foundayo trials, 8% of people stopped because of side effects, against 3% on placebo. Most of those people had gastrointestinal problems.
Foundayo may harm an unborn baby, so pregnancy should be avoided during treatment, and Foundayo must be stopped as soon as pregnancy is confirmed.
What happens when you stop Foundayo?
When you stop taking Foundayo, its effect on your appetite fades within days, and the weight you lost often returns over the following months.
| While you keep taking Foundayo | After discontinuing Foundayo | |
| Appetite | Stays reduced | Usually returns within days to two weeks. |
| Weight | Loss is maintained or continues | Regain is common over the months that follow |
| Foundayo in your body | Stays at a steady daily level | Clears in about a week |
Foundayo leaves your body gradually, over about a week after your last dose. As the medicine clears, it no longer curbs your appetite, so hunger and the pull towards larger portions come back.
In our experience with GLP-1 medicines, the speed of that change catches people off guard. Hunger comes back before the weight does, and some patients will regain some of the weight they lost.
The clearest evidence on weight re-gain comes from semaglutide, a related injectable GLP-1. In the STEP 1 trial extension, people regained about two-thirds of their lost weight within a year of stopping. They stayed a little below their starting weight on average, but most of the loss came back with time.
Researchers have not yet studied specifically what happens after stopping Foundayo. Because Foundayo works in the same way as other GLP-1 agonists, some Foundayo weight regain is likely once you come off it. The amount will vary from person to person.
Foundayo does not cause a withdrawal reaction the way some medicines do. It does not cause physical dependence, and you do not need to lower the dose in steps before stopping. The changes you feel come from your appetite returning, not from your body reacting to the medicine leaving.
How do I keep the weight I lost off?
Keeping up a healthy diet and increased physical activity can slow how much comes back. We recommend that patients spend the time they are taking a weight loss medication building new habits and preparing for your life after treatment.
How you prepare is up to you, but we recommend the following steps;
- Change your diet – look at ways to reduce your reliance on quick and easy unhealthy foods, and swap them for healthier alternatives.
- Simple substitutions – whether it’s a glass of water instead of a fizzy drink, white meat for red or quinoa for rice, there are plenty of small changes that can help in the long term.
- Start moving early – you don’t need to hit the gym and do a 5k to start moving. Adding a walk into your daily routine, alongside a few stretches and exercises, can help prepare your body for as far as you want to take your new routine.
Can you take breaks from Foundayo?
We do not recommend taking breaks from Foundayo because it only works on the days you take it.
Foundayo only works while it is active in your body, so its effects wear off during any break. Any weight you have lost can begin coming back. Restarting also brings a higher chance of side effects. Your body needs to adjust to the medicine all over again.
A few pauses are genuinely necessary, though. If you become pregnant, stop Foundayo and tell your prescriber straight away – it may harm an unborn baby. If you are planning a pregnancy, speak to your prescriber before you start trying.
Tell your health care team about Foundayo before any planned operation or procedure. Foundayo slows how quickly your stomach empties. Food can then stay in your stomach even after a normal pre-op fast. This raises the risk of it entering your lungs under anaesthetic. Surgical teams will guide you and plan around it once they know.
You can restart Foundayo safely after a break, but you may have lost some tolerance while off the medicine. This will depend on the length of your treatment gap. Miss fewer than seven days, and you can take your next dose as usual, without doubling up.
After seven or more missed days, the US prescribing information says to restart your Foundayo dosage from a lower strength and climb again. The doses of Foundayo step up in stages to limit stomach side effects.
Foundayo does not have a UK licence yet, and we cannot prescribe it. If you already take Foundayo, the prescriber who started you knows your history best. Talk to them or your GP before you stop or restart.
Who should not take Foundayo?
Foundayo is not suitable for everyone, and some people should not take it at all.
The US prescribing information says you should not take Foundayo if you or a close family member has had medullary thyroid cancer (MTC). MTC is a rare cancer of the thyroid gland. You should also avoid Foundayo if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). This is an inherited condition that raises the risk of certain tumours.
The thyroid warnings for Foundayo come from the United States, where it holds a licence. If you have a personal or family history of thyroid cancer or any active cancer of any type, tell us before starting any GLP-1 medicine.
When should I see a doctor?
Stopping Foundayo is not usually a medical emergency, but some symptoms need prompt attention. This applies whether you are still taking it or coming off it.
Speak to our clinical team about:
- Questions about whether to stop, pause, or restart your GLP-1 medication, including Foundayo
- Mild nausea, vomiting, constipation, or diarrhoea that you can still manage
- How to hold onto your results as your appetite returns
Contact your GP or call NHS 111 if you have:
- Yellowing of your skin or the whites of your eyes, or severe pain in your upper-right stomach
- A lump in your neck, a hoarse voice, or trouble swallowing that does not settle
- Vomiting or diarrhoea so severe that you cannot keep fluids down
- Symptoms of low blood sugar, if you also take insulin or a sulfonylurea for diabetes
Stop Foundayo and call 999 or go to A&E if you notice any of the following:
- Swelling of your face, lips, or throat, or trouble breathing
- Severe stomach pain that spreads to your back
- Signs of severe dehydration, such as feeling dizzy or passing little urine
- If you have thoughts of harming yourself, go to A&E and ask for the CRISIS team
Frequently asked questions
Will I regain weight after I quit Foundayo?
Some weight re-gain is likely after you quit Foundayo, though it rarely happens all at once. In studies of similar GLP-1 medicines, people regained much of their lost weight within a year of stopping. Many remained a little below their starting point. Keeping up long-term eating habits and staying active can limit how much comes back.
How soon after stopping does appetite come back?
Appetite usually returns within one to two weeks of stopping Foundayo, as the medicine clears from your body. Foundayo leaves the body over about a week, so the effect fades gradually rather than all at once. What happens after Foundayo is mostly a return of normal hunger, not a withdrawal reaction.
Does coming off Foundayo cause withdrawal symptoms?
Coming off Foundayo does not cause a classic withdrawal reaction because the medicine is not addictive. Foundayo withdrawal is the return of your appetite and, over time, some weight regain. You may feel hungrier than you did on treatment, but you should not feel physically unwell from stopping on its own.
Can I restart Foundayo after stopping?
Yes, you can restart Foundayo after stopping, and many people do. You may need to build the dose up again from a lower strength. Your stomach loses tolerance while you are off Foundayo, and going straight back to your old dose can bring the nausea back with it.
Climbing the steps a second time gives your body room to adjust. Once you reach a full dose again, appetite and weight loss usually respond as they did before.
Is it safe to stop Foundayo suddenly?
Stopping Foundayo suddenly is generally safe, and you do not need to lower the dose in steps first. Diabetes is the exception worth pausing on.
If you also take insulin or a sulfonylurea, tell whoever manages your diabetes before you stop. Those doses were probably lowered while the GLP-1 was doing some of the work, and may need to be increased. Appetite comes back either way, and we can help you plan for that part.
Key takeaways
- Foundayo is a long-term treatment: obesity tends to return when the medicine stops.
- Your appetite comes back within one to two weeks of your last dose.
- If you hold onto a healthy diet and increased physical activity through the months after stopping, less of the weight comes back.
- Make your plan while the medicine is still working, not after the weight returns.
- Stopping Foundayo causes no physical withdrawal, and you can stop without tapering the dose.
References
UK first in Europe to authorise orforglipron for weight management and type 2 diabetes, gov.uk [Accessed 10 August 2026.]
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1), New England Journal of Medicine, 2025 [Accessed 15 July 2026].
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension, Diabetes, Obesity and Metabolism, 2022 [Accessed 15 July 2026].
Foundayo (orforglipron) tablets: US prescribing information, U.S. Food and Drug Administration, 2026 [Accessed 15 July 2026].
Foundayo Summary of Product Characteristics, electronic medicines compendium, 2026 [Accessed 18 August 2026].
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement, Anaesthesia, 2025 [Accessed 15 July 2026].
Authorship

Authored by Shereen Amin
Pharmacist Independent Prescriber & Medical Writer
GPhC: 2073003
Shereen is a Pharmacist Independent Prescriber and medical writer with over ten years' experience across NHS primary care, digital health and specialist services. She writes evidence-based health content for Simple Online Pharmacy, turning complex clinical information into guidance patients can actually use.

Medically Reviewed by Richard Wood
Pharmacist / Clinical Specialist
GPhC reg:
2078802
Richard is a pharmacist and content reviewer at Simple Online Pharmacy. He officially joined the team in 2024 after several years of working with the company as a contractor. Prior to that, he spent over 11 years as a community pharmacist, building a strong foundation in patient care.